Cargando…

Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units

OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Lucas Miyake, da Silva, Daniella Matsubara, Comarella, Larissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176057/
https://www.ncbi.nlm.nih.gov/pubmed/27578187
http://dx.doi.org/10.1016/j.rppede.2016.04.001
_version_ 1782484757822570496
author Okumura, Lucas Miyake
da Silva, Daniella Matsubara
Comarella, Larissa
author_facet Okumura, Lucas Miyake
da Silva, Daniella Matsubara
Comarella, Larissa
author_sort Okumura, Lucas Miyake
collection PubMed
description OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these services to children and adolescents care has led to interesting results, but certainly are under reported. This short report aims to discuss the effect of implementing a bedside CPS at a Brazilian Pediatric Intensive Care Unit (PICU). METHODS: This is a cross-sectional study conducted in a 12 bed PICU community hospital, from Campo Largo/Brazil. Subjects with<18 years old admitted to PICU were included for descriptive analysis if received a CPS intervention. RESULTS: Of 53 patients accompanied, we detected 141 preventable drug-related problems (DRPs) which were solved within clinicians (89% acceptance of all interventions). The most common interventions performed to improve drug therapy included: preventing incompatible intravenous solutions (21%) and a composite of inadequate doses (17% due to low, high and non-optimized doses). Among the top ten medications associated with DRPs, five were antimicrobials. By analyzing the correlation between DRPs and PICU length of stay, we found that 74% of all variations on length of stay were associated with the number of DRPs. CONCLUSIONS: Adverse drug reactions due to avoidable DRPs can be prevented by CPS in a multifaceted collaboration with other health care professionals, who should attempt to use active and evidence-based strategies to reduce morbidity related to medications.
format Online
Article
Text
id pubmed-5176057
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Sociedade de Pediatria de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-51760572017-01-04 Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units Okumura, Lucas Miyake da Silva, Daniella Matsubara Comarella, Larissa Rev Paul Pediatr Original Articles OBJECTIVE: Clinical Pharmacy Services (CPS) are considered standard of care and is endorsed by the Joint Commission International, the American Academy of Pediatrics, and the American College of Clinical Pharmacy. In Brazil, single experiences have been discreetly arising and the importance of these services to children and adolescents care has led to interesting results, but certainly are under reported. This short report aims to discuss the effect of implementing a bedside CPS at a Brazilian Pediatric Intensive Care Unit (PICU). METHODS: This is a cross-sectional study conducted in a 12 bed PICU community hospital, from Campo Largo/Brazil. Subjects with<18 years old admitted to PICU were included for descriptive analysis if received a CPS intervention. RESULTS: Of 53 patients accompanied, we detected 141 preventable drug-related problems (DRPs) which were solved within clinicians (89% acceptance of all interventions). The most common interventions performed to improve drug therapy included: preventing incompatible intravenous solutions (21%) and a composite of inadequate doses (17% due to low, high and non-optimized doses). Among the top ten medications associated with DRPs, five were antimicrobials. By analyzing the correlation between DRPs and PICU length of stay, we found that 74% of all variations on length of stay were associated with the number of DRPs. CONCLUSIONS: Adverse drug reactions due to avoidable DRPs can be prevented by CPS in a multifaceted collaboration with other health care professionals, who should attempt to use active and evidence-based strategies to reduce morbidity related to medications. Sociedade de Pediatria de São Paulo 2016 /pmc/articles/PMC5176057/ /pubmed/27578187 http://dx.doi.org/10.1016/j.rppede.2016.04.001 Text en © 2016 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Okumura, Lucas Miyake
da Silva, Daniella Matsubara
Comarella, Larissa
Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title_full Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title_fullStr Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title_full_unstemmed Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title_short Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units
title_sort relation between safe use of medicines and clinical pharmacy services at pediatric intensive care units
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176057/
https://www.ncbi.nlm.nih.gov/pubmed/27578187
http://dx.doi.org/10.1016/j.rppede.2016.04.001
work_keys_str_mv AT okumuralucasmiyake relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits
AT dasilvadaniellamatsubara relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits
AT comarellalarissa relationbetweensafeuseofmedicinesandclinicalpharmacyservicesatpediatricintensivecareunits